Apotex Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apotex Inc. - overview
Established
1974
Location
Toronto, ON, Canada
Primary Industry
Pharmaceuticals
About
Apotex Pharmaceutical Holdings Inc. is a prominent player in the pharmaceutical industry, concentrating on the development and distribution of generic, biosimilar, and innovative specialty medicines to enhance patient health outcomes. Apotex Inc. is engaged in the development and manufacturing of pharmaceutical products.
Founded in 1974, Apotex Inc. is engaged in the development and manufacturing of pharmaceutical products. Founded in 1974, the company is headquartered in Toronto, Canada. In September 2022, SK Capital agreed to acquire Apotex Pharmaceutical Holdings Inc for approximately USD 3 billion.
The transaction was completed in April 2023. Apotex Inc. specializes in the development, manufacturing, and distribution of a wide array of pharmaceutical products, with a primary focus on generics, biosimilars, and innovative specialty medicines. These core offerings aim to improve patient health outcomes by providing accessible, affordable medications across various therapeutic areas, including cardiovascular health, infectious diseases, and chronic conditions.
Apotex serves a diverse clientele, including healthcare providers and patients across multiple regions, including the United States, Canada, Mexico, and Saudi Arabia. Apotex operates on a revenue model that includes business-to-business transactions with wholesalers, retailers, and healthcare institutions. Income is generated through the sale of its pharmaceutical products, supplied to healthcare providers under contractual agreements, which involve negotiated pricing and volume commitments. The company's flagship products, which include a range of generic and specialty medications, are crucial to its revenue stream and support public health initiatives as well as individual patient needs.
The acquisition by SK Capital will enable Apotex Pharmaceutical Holdings Inc. to support its next phase of growth and continued innovation for patient affordability. The company is expected to invest in upcoming new products aimed at expanding its market presence. Specific targeted regions for expansion are yet to be disclosed, but the focus will be on enhancing accessibility in existing markets.
Apotex plans to leverage this funding to solidify its standing in the pharmaceutical sector and advance its product development initiatives.
Current Investors
SK Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.apotex.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Apotex Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Announced | Cumberland Pharmaceuticals Inc.'s branded commercial pharmaceutical portfolio | - | ||||||||
| Add-on | Completed | CanPrev Natural Health Products, Ltd. | - | ||||||||
| Add-on, Trade Sale | Completed | Searchlight Pharma Inc. | - | ||||||||
| N/A | Completed | - | |||||||||
| Buyout | Completed | Apotex Inc. | - |
Displaying 1 - 5 of 8
Apotex Inc. - employee data
Apotex Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Director | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.